Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Tilmicosin phosphate" patented technology

Tilmicosin phosphate is a antibiotic, is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.

Detection method for residual solvent in tilmicosin phosphate

ActiveCN103645252AConstant temperature detection is simpleEasy to operateComponent separationChromatographic separationGas phase
A detection method for a residual solvent in tilmicosin phosphate comprises: preparing a reference substance solution, preparing a to-be-detected sample solution, employing a gas chromatography method, injecting the reference substance solution and the to-be-detected sample solution into a gas chromatograph by a headspace sampling manner, and calculating the residual quantity according to an external standard method. Through optimization of chromatographic conditions and the tests on preparation methods of the to-be-detected sample and the reference substance, a gas chromatograph method is established for detecting residues such as butyl acetate and n-butanol possibly existing in tilmicosin phosphate; through optimization of the chromatographic separation system, the detection method for the residual solvent in the veterinary drug tilmicosin phosphate; methodological verification tests show that the established method is high in accuracy, strong in specificity and good in reproducibility; and by controlling the content of the residual solvent in the veterinary drug tilmicosin phosphate, the safety of the veterinary drug tilmicosin phosphate is guaranteed, and thus infectious diseases of animals such as cattle, goat, sheep, cow, pig, chicken and the like are relatively effectively controlled.
Owner:宁夏泰瑞制药股份有限公司

Veterinary compound florfenicol injection and preparation method thereof

The invention discloses compound florfenicol injection and a preparation method thereof. The compound florfenicol injection comprises the following components: 500g of florfenicol, 500g of doxycycline hyclate, 500g of tilmicosin phosphate, 3,000g of polyvinylpyrrolidone, 4,000g of N, N-dimethylacetylamide, 200g of magnesium chloride, 20g of sodium formaldehyde sulphoxylate and 10,000 milliliters of water for injection. The preparation method comprises the following steps of: (1) preparing; (2) adding doxycycline into the polyvinylpyrrolidone, heating to 80 DEG C, stirring until a mixture is clarified, adding the tilmicosin phosphate, and stirring until a mixture is clarified; (3) heating dimethylacetylamide to 50 DEG C, adding the florfenicol, and stirring for dissolving; (4) adding 1,000 milliliters of water for injection, adding the magnesium chloride and the sodium formaldehyde sulphoxylate in turn, and stirring for dissolving; and (5) mixing solution prepared in the step (2) and the step (3), gradually adding solution prepared in the step (4) under stirring, replenishing the water for injection until the total volume of the water for injection is 10,000 milliliters, uniformly stirring, filtering, filling nitrogen, encapsulating, and sterilizing at the temperature of between 110 and 115 DEG C for 30 minutes to prepare the compound florfenicol injection.
Owner:HUBEI WUDANG ANIMAL PHARMA

Method for producing tilmicosin and tilmicosin phosphate by utilizing tylosin fermentation broth

InactiveCN108864227ARepeatedly adjust the pHThe production process route is short and efficientSugar derivativesSugar derivatives preparationOrganic solventPhosphoric acid
The invention belongs to the field of pharmacy and particularly discloses a method for producing tilmicosin and tilmicosin phosphate by utilizing a tylosin fermentation broth. The method comprises thefollowing steps of performing hydrolysis pretreatment and filtering on the tylosin fermentation broth to obtain a tylosin B filtrate, then performing extraction separation on the tylosin B filtrate,performing catalyzed synthesis to obtain the tilmicosin, performing water-phase extraction, decoloration, crystallization and solid-liquid separation to obtain a wet tilmicosin solid, and drying the wet tilmicosin solid to obtain a tilmicosin product, or dissolving the wet tilmicosin solid with strong phosphoric acid to prepare a tilmicosin phosphate product. In the method, by directly taking thetylosin fermentation broth as a starting material to extract and synthesize the tilmicosin product or the tilmicosin phosphate product, the production technology is simplified, the production time isremarkably shortened, the production efficiency is improved, the yield of the product is increased, the quality of the product is improved, the production cost is lowered, loss of an organic solvent is reduced, emission of the three wastes is remarkably reduced, and the method has the advantages of energy conservation, consumption reduction, safe environment, excellent quality, cost reduction andthe like.
Owner:CHINA ANIMAL HUSBANDRY IND

Traditional Chinese and western medicine compound oral liquid for treating porcine respiratory disease, and preparation method and application of compound oral liquid

InactiveCN107998265AMask bitternessOvercome the major difficulty of severe decline in feed intakeOrganic active ingredientsDispersion deliveryDiseaseSucrose
The invention relates to traditional Chinese and western medicine compound oral liquid for treating a porcine respiratory disease, and a preparation method and an application of the compound oral liquid, and belongs to the field of veterinary medicines. The preparation method of the traditional Chinese and western medicine compound oral liquid comprises the following steps of dissolving a folium eriobotryae extract, a fritillaria cirrhosa extract, tilmicosin phosphate, menthol, essence, sucrose and an auxiliary material. The preparation method is simple, good in condition controllability, lowin production cost and high in stability and has good application prospects. The traditional Chinese and western medicine compound oral liquid prepared by the method can effectively cover bitterness of an ordinary tilmicosin medicine, overcome the great difficulty of serious reduction of porcine feed intake caused by an ordinary tilmicosin pharmaceutical preparation and avoid resistance to the tilmicosin medicine, and has the advantages that the oral liquid takes effect quickly, is absorbed well, and is low in waste and cost. The oral liquid is used for preparing a medicine for treating or preventing the porcine respiratory disease, and has a better treatment effect on the porcine respiratory disease and only smaller influence on the porcine feed intake.
Owner:FUJIAN AONONG BIOLOGICAL TECH GRP CO LTD +1

Three-stage composition for preventing and controlling porcine respiratory diseases and application thereof

ActiveCN106721319APrevent and manage the risk of respiratory diseasesReduce morbidityOrganic active ingredientsFood processingComposition BRespiratory disease
The present invention discloses a three-stage composition for preventing and controlling porcine respiratory diseases. The composition comprises a composition A used in weaning period of piglets, a composition B used in conservation period and a composition C used in fattening period. The composition A comprises fermented licorice extract, folium artemisiae argyi extract, loquat leaf extract, a coated tilmicosin phosphate preparation and zeolite powder; the composition B comprises echinacea purpurea extract and radix astragali extract; and the composition C comprises corns, soybean meal, wheat bran and homemade special premixes. In addition, the present invention also discloses an application of the three-stage composition used for preparing feed additives or feeds for preventing and controlling the porcine respiratory diseases. According to the occurrence regularity of the respiratory diseases of live pigs, the different compositions in the three stages are firstly used to prevent and control the occurrence of the porcine respiratory diseases. The three-stage composition is very ideal in effects, can effectively prevent and control the occurrence of the respiratory diseases and has the characteristics of being accurate in curative effects, not easy to produce drug resistance and relapse, etc.
Owner:CHANGSHA LVYE BIOTECHNOLOGY CO LTD

Production method for coating tilmicosin by agar

The invention relates to the field of veterinary drugs and preparation, in particular to a production method for coating tilmicosin by agar. The method includes the following steps that A, tilmicosin powder is weighed or high-concentration tilmicosin phosphate solution is prepared; B, agar powder is weighed, distilled water is added to the agar powder, and the mixture is heated to be melted; C, when the agar solution is cooled to be not hot and kept in the solution state, a proper amount of tilmicosin powder or tilmicosin mother solution is added to the agar solution, the final concentration of the agar is made to be larger than 0.8% (coating the tilmicosin powder) or larger than 0.5% (coating the tilmicosin phosphate solution), the mixture is evenly mixed and then poured into a container in a required shape, and a product is obtained after the mixture is fully cooled and solidified; D, sample detection is conducted on the product, and the effects of covering up the bitter taste and slow release of the product are detected; E, packaging is conducted. According to the production method, the tilmicosin is coated by the agar, the bitter taste of the tilmicosin is covered up, meanwhile the slow release function is achieved, and the coating medium agar further has the effects of improving the animal intestine and gastrointestinal motility, improving the immunity and the like.
Owner:芜湖神农百草生物科技有限公司

Detection method for residual solvent in tilmicosin phosphate

ActiveCN103645252BConstant temperature detection is simpleEasy to operateComponent separationBiotechnologyChromatographic separation
A detection method for a residual solvent in tilmicosin phosphate comprises: preparing a reference substance solution, preparing a to-be-detected sample solution, employing a gas chromatography method, injecting the reference substance solution and the to-be-detected sample solution into a gas chromatograph by a headspace sampling manner, and calculating the residual quantity according to an external standard method. Through optimization of chromatographic conditions and the tests on preparation methods of the to-be-detected sample and the reference substance, a gas chromatograph method is established for detecting residues such as butyl acetate and n-butanol possibly existing in tilmicosin phosphate; through optimization of the chromatographic separation system, the detection method for the residual solvent in the veterinary drug tilmicosin phosphate; methodological verification tests show that the established method is high in accuracy, strong in specificity and good in reproducibility; and by controlling the content of the residual solvent in the veterinary drug tilmicosin phosphate, the safety of the veterinary drug tilmicosin phosphate is guaranteed, and thus infectious diseases of animals such as cattle, goat, sheep, cow, pig, chicken and the like are relatively effectively controlled.
Owner:宁夏泰瑞制药股份有限公司

Method for preparing efficient tilmicosin premixing agent through adsorption crystallization and application of efficient tilmicosin premixing agent

The invention relates to A61K, in particular to a method for preparing an efficient tilmicosin premixing agent through adsorption crystallization and application of the efficient tilmicosin premixing agent. Comprising the following steps: adsorption crystallization: spraying a tilmicosin mixed solution into a porous material, and carrying out boiling drying at 50-100 DEG C for 10-15 minutes; by controlling the water content and the adsorption capacity of the porous material, adsorption of the tilmicosin mixed solution is promoted, and meanwhile, solvent water and the like in the tilmicosin mixed solution are controlled to be taken out by sucking and discharging boiling dry airflow at a certain temperature in a pore channel of the porous material with high adsorption capacity; therefore, the tilmicosin or the tilmicosin phosphate is promoted to rapidly crystallize in a short time and is adsorbed in the pore channels of the porous material to form adsorption crystals. Plant extract components can be further added after adsorption and crystallization, so that the effects of enhancing immunity, resisting inflammation, resisting oxidation, improving drug effects, reducing side effects of drugs and the like are achieved, or the taste of the preparation is improved, and the first-mouth selectivity and the long-term feed intake are improved.
Owner:HUNAN DANWEI BILOGICALTECH

Veterinary compound florfenicol injection and preparation method thereof

The invention discloses compound florfenicol injection and a preparation method thereof. The compound florfenicol injection comprises the following components: 500g of florfenicol, 500g of doxycycline hyclate, 500g of tilmicosin phosphate, 3,000g of polyvinylpyrrolidone, 4,000g of N, N-dimethylacetylamide, 200g of magnesium chloride, 20g of sodium formaldehyde sulphoxylate and 10,000 milliliters of water for injection. The preparation method comprises the following steps of: (1) preparing; (2) adding doxycycline into the polyvinylpyrrolidone, heating to 80 DEG C, stirring until a mixture is clarified, adding the tilmicosin phosphate, and stirring until a mixture is clarified; (3) heating dimethylacetylamide to 50 DEG C, adding the florfenicol, and stirring for dissolving; (4) adding 1,000 milliliters of water for injection, adding the magnesium chloride and the sodium formaldehyde sulphoxylate in turn, and stirring for dissolving; and (5) mixing solution prepared in the step (2) and the step (3), gradually adding solution prepared in the step (4) under stirring, replenishing the water for injection until the total volume of the water for injection is 10,000 milliliters, uniformly stirring, filtering, filling nitrogen, encapsulating, and sterilizing at the temperature of between 110 and 115 DEG C for 30 minutes to prepare the compound florfenicol injection.
Owner:HUBEI WUDANG ANIMAL PHARMA

A "three-stage" composition for preventing and controlling porcine respiratory diseases and its application

ActiveCN106721319BEffective collaborative prevention and control of respiratory diseasesCollaborative prevention and control of respiratory diseasesOrganic active ingredientsFood processingBiotechnologyDisease
The present invention discloses a three-stage composition for preventing and controlling porcine respiratory diseases. The composition comprises a composition A used in weaning period of piglets, a composition B used in conservation period and a composition C used in fattening period. The composition A comprises fermented licorice extract, folium artemisiae argyi extract, loquat leaf extract, a coated tilmicosin phosphate preparation and zeolite powder; the composition B comprises echinacea purpurea extract and radix astragali extract; and the composition C comprises corns, soybean meal, wheat bran and homemade special premixes. In addition, the present invention also discloses an application of the three-stage composition used for preparing feed additives or feeds for preventing and controlling the porcine respiratory diseases. According to the occurrence regularity of the respiratory diseases of live pigs, the different compositions in the three stages are firstly used to prevent and control the occurrence of the porcine respiratory diseases. The three-stage composition is very ideal in effects, can effectively prevent and control the occurrence of the respiratory diseases and has the characteristics of being accurate in curative effects, not easy to produce drug resistance and relapse, etc.
Owner:CHANGSHA LVYE BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products